Drug-Induced Liver Injury: Getting the Medicine and Science Together  

|

AASLD/FDA/PhRMA Drug-Induced Liver Injury: Getting the Medicine and Science Together
Note: This course was held March 24-25, 2010
George Meany Center National Labor College, Silver Spring, Maryland

Final Program, Transcripts, and Presentations

Course Description
A national/international discussion of recent clinical and basic findings in the field of drug-induced liver injury (DILI), with presentations by experts in clinical hepatology and scientific investigation of underlying mechanisms, to include active discussion with interested audience registrants. We invite your comments about the tentative program, and ask you to save the date, plan to register, come, and participate actively in this not-for-profit conference.

The program is being co-sponsored by the Food and Drug Administration/Center for Drug Evaluation and Research (FDA/CDER), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the American Association for the Study of Liver Disease (AASLD).